Decreased Plasma Nesfatin-1 Level Is Related to the Thyroid Dysfunction in Patients with Type 2 Diabetes Mellitus

Decreased Plasma Nesfatin-1 Level Is Related to the Thyroid Dysfunction in Patients with Type 2 Diabetes Mellitus

Aims. Thyroid dysfunction is frequently observed in patients with type 2 diabetes mellitus (T2DM), but the underlying mechanism is still poorly understood. The present study aimed to investigate whether nesfatin-1 played a role in the thyroid dysfunction in patients with T2DM. Methods. 55 euthyroid...

Full description

Saved in:

Bibliographic Details
Main Authors:	Fupeng Liu, Qing Yang, Ning Gao, Fangfang Liu, Shaohua Chen
Format:	Article
Language:	English
Published:	Wiley 2014-01-01
Series:	Journal of Diabetes Research
Online Access:	http://dx.doi.org/10.1155/2014/128014
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Relationship between serum Nesfatin-1, Adiponectin, Resistin Concentration, and Obesity with Type 2 Diabetes Mellitus
by: Baydaa Ahmed Abed, et al.
Published: (2024-01-01)

Thyroid Dysfunction in Patients with Type 2 Diabetes Mellitus
by: Annia Quintana Marrero, et al.
Published: (2020-09-01)

Serum levels of irisin and nesfatin-1 in multiple sclerosis
by: Mustafa ALTAŞ, et al.
Published: (2022-02-01)

Evaluation of Nesfatin–1 levels in ewes with pregnancy toxemia
by: Ömer Yaprakci, et al.
Published: (2025-08-01)

Abnormal insulin metabolism and decreased levels of mindfulness in type 2 diabetes mellitus
by: Xue Zhang, et al.
Published: (2025-01-01)

Assessment of the Influence of Adiponectin, Nesfatin-1, Insulin Resistance, and Various Biochemical Parameters in Samples of Iraqi Individuals Diagnosed with Type 2 Diabetes Mellitus and Pre-diabetes
by: Abdullah Abdulsattar Raeef, et al.
Published: (2025-03-01)

Association Between Plasma ADAMTS-7 Levels and Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus
by: Asimina Ganotopoulou, et al.
Published: (2024-12-01)

The effect of breast milk nesfatin-1 and ghrelin levels on growth in infants with SGA
by: Berna Eroğlu Filibeli, et al.
Published: (2022-04-01)

THE RELATION OF SERUM NESFATIN-1 LEVELS WITH DISEASE SEVERITY AND COMPLICATIONS IN PATIENTS WITH LIVER CIRRHOSIS
by: Özlem Kandemir Alibakan, et al.
Published: (2024-07-01)

Thyroid Dysfunction and Associated Risk Factors among Nepalese Diabetes Mellitus Patients
by: Saroj Khatiwada, et al.
Published: (2015-01-01)

Elevated thyroid autoantibodies as risk factors for metabolic dysfunction-associated fatty liver disease in type 2 diabetes mellitus
by: Wenchang Wu, et al.
Published: (2024-12-01)

Assessment of Irisin and Nesfatin-1 Levels in Non-Obese and Obese Women with Polycystic Ovarian Syndrome
by: Ali Al-Sajaad Mohammed Al-Azzawi, et al.
Published: (2025-04-01)

Thyroid Dysfunction among Greek Patients with Type 1 and Type 2 Diabetes Mellitus as a Disregarded Comorbidity
by: Maria E. Barmpari, et al.
Published: (2017-01-01)

Associations between serum JAML, nesfatin-1, and 25(OH)D and the risk of diabetic kidney disease in patients with type 2 diabetes
by: Qizhuo Hou, et al.
Published: (2025-07-01)

Assessment of Thyroid Dysfunction and Thyroid Auto-Antibodies in Type 1 Diabetes
by: Hajieh BiBi Shahbazian, et al.
Published: (2012-03-01)

Biological variation in serum thyroid, iron metabolism, and plasma bone metabolism biomarkers in patients with type 2 diabetes mellitus
by: Xia Wang, et al.
Published: (2025-05-01)

Association Between Thyroid Function Parameters and Plasma Branched-Chain Amino and Keto Acids in Patients With Euthyroid Type 2 Diabetes Mellitus
by: Xinghua Cai, et al.
Published: (2025-01-01)

Level and Statistical Distribution of Thyroid Peroxidase and Thyroid Hormones in Iraqi patients with Type1 Diabetes Mellitus at Al-Karkh Side
by: Baghdad Science Journal
Published: (2016-06-01)

Decreased Extracellular Vesicle Vasorin in Severe Preeclampsia Plasma Mediates Endothelial Dysfunction
by: Saravanakumar Murugesan, et al.
Published: (2025-04-01)

Nesfatin-1 as a crucial mediator of glucose homeostasis in the reptile, Hemidactylus flaviviridis
by: Krittika Dotania, et al.
Published: (2024-12-01)

Thyroid disorders among patients with type II Diabetes Mellitus
by: Mariwan Abdulla Hama Salih
Published: (2019-08-01)

PDX1 in early pregnancy is associated with decreased risks of gestational diabetes mellitus and adverse pregnancy outcomes
by: Qian Zhang, et al.
Published: (2025-05-01)

The Correlation Between Impaired Thyroid Hormone Sensitivity and Diabetic Nephropathy in Euthyroid Patients with Type 2 Diabetes Mellitus
by: Ma D, et al.
Published: (2025-04-01)

The Influence of Bariatric Surgery on Matrix Metalloproteinase Plasma Levels in Patients with Type 2 Diabetes Mellitus
by: João Kleber de Almeida Gentile, et al.
Published: (2024-12-01)

Decreased Levels of Insulin-Regulated Aminopeptidase (IRAP) in Gestational Diabetes Mellitus: A Prospective Cohort Study
by: Osman Köse, et al.
Published: (2025-01-01)

Increased Serum Levels and Chondrocyte Expression of Nesfatin-1 in Patients with Osteoarthritis and Its Relation with BMI, hsCRP, and IL-18
by: Lifeng Jiang, et al.
Published: (2013-01-01)

Nesfatin-1 expression and blood plasma concentration in female dogs suffering from cystic endometrial hyperplasia and pyometra and its possible interaction with phoenixin-14
by: Marta Rybska, et al.
Published: (2024-10-01)

The Relationship between Type 2 Diabetes Mellitus and Related Thyroid Diseases
by: Chaoxun Wang
Published: (2013-01-01)

The Effect of Mild Renal Dysfunction on the Assessment of Plasma Amino Acid Concentration and Insulin Resistance in Patients with Type 2 Diabetes Mellitus
by: Hideki Ikeda
Published: (2022-01-01)

Impact of Diabetic Ketoacidosis on Thyroid Function in Patients with Diabetes Mellitus
by: Yuling Xing, et al.
Published: (2021-01-01)

Case Report: SARS-CoV-2-associated immune dysfunction manifesting as concurrent fulminant type 1 diabetes mellitus and subacute thyroiditis
by: Wei Fang, et al.
Published: (2025-08-01)

The effect of periodontal health and disease on interleukin 1β and nesfatin-1 levels in gingival crevicular fluid: A cross-sectional study
by: Meral Uzunkaya, et al.
Published: (2024-07-01)

Decreased ultrasound echogenicity as a thyroid hypofunction marker and correlation with autoantibody levels
by: Dimić Dragan, et al.
Published: (2018-01-01)

The role of the Mediterranean diet in the treatment of cognitive dysfunction in patients with type 2 diabetes mellitus
by: Chunyan Zheng, et al.
Published: (2025-08-01)

Impaired sensitivity to thyroid hormones is associated with high lipoprotein(a) level in euthyroid patients with type 2 diabetes mellitus
by: Luojing Zhong, et al.
Published: (2025-06-01)

Decreased Plasma Maresin 1 Concentration Is Associated with Diabetic Foot Ulcer
by: Tian Miao, et al.
Published: (2020-01-01)

Serum Irisin Levels, Endothelial Dysfunction, and Inflammation in Pediatric Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome
by: Anna S. Huerta-Delgado, et al.
Published: (2020-01-01)

Plasma Antimicrobial Peptide LL-37 Level Is Inversely Associated with HDL Cholesterol Level in Patients with Type 2 Diabetes Mellitus
by: Shu Meguro, et al.
Published: (2014-01-01)

A Study of Thyroid-Stimulating Hormone in Patients with Type 2 Diabetes Mellitus
by: Mahmood Dhahir Al-Mendalawi
Published: (2024-01-01)

Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes
by: Eun Shil Hong, et al.
Published: (2019-05-01)